ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 257 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q1 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,094,000 | -47.0% | 26,429 | -23.6% | 0.02% | -17.2% |
| Q2 2022 | $2,065,000 | -31.5% | 34,613 | -16.6% | 0.03% | -14.7% |
| Q1 2022 | $3,013,000 | -64.1% | 41,492 | -58.4% | 0.03% | -56.4% |
| Q4 2021 | $8,384,000 | -73.6% | 99,698 | -71.6% | 0.08% | -74.5% |
| Q3 2021 | $31,702,000 | -16.7% | 351,499 | -11.9% | 0.31% | -9.7% |
| Q2 2021 | $38,062,000 | -21.2% | 399,181 | -5.8% | 0.34% | -24.5% |
| Q1 2021 | $48,272,000 | -28.2% | 423,957 | -12.7% | 0.45% | -28.0% |
| Q4 2020 | $67,258,000 | +70.2% | 485,866 | +1.0% | 0.62% | +43.4% |
| Q3 2020 | $39,520,000 | +5.7% | 480,833 | +0.6% | 0.44% | -4.6% |
| Q2 2020 | $37,378,000 | +86.7% | 477,858 | +6.1% | 0.46% | +35.3% |
| Q1 2020 | $20,015,000 | +5.9% | 450,495 | +1.8% | 0.34% | +28.1% |
| Q4 2019 | $18,906,000 | -6.2% | 442,660 | -6.0% | 0.26% | -13.2% |
| Q3 2019 | $20,152,000 | +324.4% | 471,065 | +530.1% | 0.30% | -8.7% |
| Q2 2019 | $4,748,000 | +42.5% | 74,765 | +55.6% | 0.33% | -16.4% |
| Q1 2019 | $3,333,000 | +74.4% | 48,050 | +9.4% | 0.40% | +52.1% |
| Q4 2018 | $1,911,000 | -44.2% | 43,941 | -2.0% | 0.26% | -41.6% |
| Q3 2018 | $3,423,000 | +30.8% | 44,841 | +31.7% | 0.45% | +11.8% |
| Q2 2018 | $2,617,000 | +24.7% | 34,040 | -17.3% | 0.40% | +32.0% |
| Q1 2018 | $2,098,000 | +4.6% | 41,140 | -4.9% | 0.30% | +1.7% |
| Q4 2017 | $2,005,000 | -18.3% | 43,240 | -6.2% | 0.30% | -17.0% |
| Q3 2017 | $2,455,000 | -25.0% | 46,100 | -12.5% | 0.36% | -23.3% |
| Q2 2017 | $3,273,000 | -15.3% | 52,700 | -7.5% | 0.47% | -0.4% |
| Q1 2017 | $3,863,000 | +16.6% | 57,000 | +21.0% | 0.47% | +14.1% |
| Q4 2016 | $3,312,000 | +32.6% | 47,100 | +33.8% | 0.41% | +38.7% |
| Q3 2016 | $2,497,000 | – | 35,200 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
| RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
| First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
| CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
| Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
| Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
| SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |